78
42
Growth Score 78 in past quarter
-8 pts
Heat Score 42 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
695684
KLIFO provides end-to-end expert capabilities, enabling partners to maximise opportunity, mitigate risks.
- Inge Tarnow: Project DirectorPast Role: Savara Pharmaceuticals, Senior Director, Head of Nonclinical Development and Project Lead
About the Company
KLIFO provides end-to-end expert capabilities, enabling partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. The company offers multidisciplinary consulting and operational solutions spanning all clinical research areas, clinical trial supply, QA, CMC development, regulatory affairs,
pharmacovigilance, and the development of pharmaceutical and biotech products and medical devices.
